{"url":"https://lda.gov/api/v1/filings/9e6b13d6-bff3-4a04-8f42-da762701c24b/","filing_uuid":"9e6b13d6-bff3-4a04-8f42-da762701c24b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/9e6b13d6-bff3-4a04-8f42-da762701c24b/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Eugenia Edwards Pierson","dt_posted":"2026-07-20T16:41:19-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Massachusetts Ave. NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":4301,"url":"https://lda.gov/api/v1/registrants/4301/","house_registrant_id":31381,"name":"ARNOLD & PORTER KAYE SCHOLER LLP","description":"Law firm","address_1":"601 Massachusetts Ave. NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS TOWNSEND","contact_telephone":"+1 202-942-5249","dt_updated":"2026-07-30T11:53:37.108571-04:00"},"client":{"id":104672,"url":"https://lda.gov/api/v1/clients/104672/","client_id":1004874,"name":"EXELIXIS, INC.","general_description":"Oncology-focused biotechnology company","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-11-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63646,"prefix":null,"prefix_display":null,"first_name":"EUGENIA","nickname":null,"middle_name":null,"last_name":"PIERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140808,"prefix":null,"prefix_display":null,"first_name":"SONJA","nickname":null,"middle_name":null,"last_name":"NESBIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63612,"prefix":null,"prefix_display":null,"first_name":"PARI","nickname":null,"middle_name":null,"last_name":"MODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102193,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"MCMILLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73516,"prefix":null,"prefix_display":null,"first_name":"CASEY","nickname":null,"middle_name":null,"last_name":"BROUHARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148538,"prefix":"mr","prefix_display":"MR.","first_name":"PETER","nickname":null,"middle_name":"ERIC","last_name":"DUYSHART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141979,"prefix":null,"prefix_display":null,"first_name":"RON","nickname":null,"middle_name":null,"last_name":"KIND","suffix":null,"suffix_display":null},"covered_position":"Member of Congress, U.S. House of Representatives (1997-2023)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (P.L. No. 117-169), including implementation and the small biotech exception. Issues related to the Small Biotech Innovation Act (S. 1930 / H.R. 3731).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":102193,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"MCMILLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73516,"prefix":null,"prefix_display":null,"first_name":"CASEY","nickname":null,"middle_name":null,"last_name":"BROUHARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148538,"prefix":"mr","prefix_display":"MR.","first_name":"PETER","nickname":null,"middle_name":"ERIC","last_name":"DUYSHART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141979,"prefix":null,"prefix_display":null,"first_name":"RON","nickname":null,"middle_name":null,"last_name":"KIND","suffix":null,"suffix_display":null},"covered_position":"Member of Congress, U.S. House of Representatives (1997-2023)","new":true},{"lobbyist":{"id":63646,"prefix":null,"prefix_display":null,"first_name":"EUGENIA","nickname":null,"middle_name":null,"last_name":"PIERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140808,"prefix":null,"prefix_display":null,"first_name":"SONJA","nickname":null,"middle_name":null,"last_name":"NESBIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63612,"prefix":null,"prefix_display":null,"first_name":"PARI","nickname":null,"middle_name":null,"last_name":"MODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}